Age-related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep

ArticleAçık Erişim

Özet

The pharmacokinetics of meloxicam was studied in 1-, 6-, and 12-month-old sheep following a single intravenous (i.v.) dose of 1 mg/kg. The experiments were carried out when the Romanov sheep were 1 month old (7.93 ± 0.91 kg), 6 months old (27.47 ± 4.91 kg), and 12 months old (37.10 ± 3.64 kg). Meloxicam concentration in plasma was determined by high-performance liquid chromatography and the data collected were evaluated by non-compartmental kinetic analysis. Meloxicam was detected in the plasma up to 72 h following i.v. administration in all age groups. The volume of distribution at steady state (Vdss) and total body clearance (ClT) were significantly higher in 1-month-old (304.87 mL/kg and 16.57 mL/h/kg) than in 12-month-old (193.43 mL/kg and 10.50 mL/h/kg) sheep. The area under the concentration–time curve from 0 to 72 h value of meloxicam was lower in 1-month-old (58.51 h*μg/mL) compared to 12-month-old (92.59 h*μg/mL) sheep. There was no difference in t1/2ʎz value in different age groups. The body extraction ratio values for meloxicam ranged from 0.0186 to 0.0719 after i.v. administration in all age groups. Meloxicam showed an increase in plasma concentration and a decrease in Vdss and ClT in 12-month-old compared to 1-month-old sheep. Compared to 1-month-old and 12-month-old sheep, there was no difference in these parameters in 6-month-old sheep. Because the age of sheep has an influence on the pharmacokinetics of meloxicam, dosage apparently may need to be adjusted for age. © 2023 John Wiley & Sons Ltd.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12172Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1111/jvp.13404Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCoskun, Devran
dc.contributor.authorCorum, Orhan
dc.contributor.authorDurna Corum, Duygu
dc.contributor.authorCetin, Gul
dc.contributor.authorIrmak, Mehmet
dc.contributor.authorCeyhan, Hatice Rumeysa
dc.contributor.authorUney, Kamil
dc.date.accessioned2026-10-18T20:27:06.455658783Z
dc.date.available2026-10-18T20:27:06.455658783Z
dc.date.issued2023
dc.description.abstractThe pharmacokinetics of meloxicam was studied in 1-, 6-, and 12-month-old sheep following a single intravenous (i.v.) dose of 1 mg/kg. The experiments were carried out when the Romanov sheep were 1 month old (7.93 ± 0.91 kg), 6 months old (27.47 ± 4.91 kg), and 12 months old (37.10 ± 3.64 kg). Meloxicam concentration in plasma was determined by high-performance liquid chromatography and the data collected were evaluated by non-compartmental kinetic analysis. Meloxicam was detected in the plasma up to 72 h following i.v. administration in all age groups. The volume of distribution at steady state (Vdss) and total body clearance (ClT) were significantly higher in 1-month-old (304.87 mL/kg and 16.57 mL/h/kg) than in 12-month-old (193.43 mL/kg and 10.50 mL/h/kg) sheep. The area under the concentration–time curve from 0 to 72 h value of meloxicam was lower in 1-month-old (58.51 h*μg/mL) compared to 12-month-old (92.59 h*μg/mL) sheep. There was no difference in t1/2ʎz value in different age groups. The body extraction ratio values for meloxicam ranged from 0.0186 to 0.0719 after i.v. administration in all age groups. Meloxicam showed an increase in plasma concentration and a decrease in Vdss and ClT in 12-month-old compared to 1-month-old sheep. Compared to 1-month-old and 12-month-old sheep, there was no difference in these parameters in 6-month-old sheep. Because the age of sheep has an influence on the pharmacokinetics of meloxicam, dosage apparently may need to be adjusted for age. © 2023 John Wiley & Sons Ltd.
dc.description.sponsorshipThis study was supported by the Coordination of Scientific Research Projects, University of Erzincan Binali Yıldırım, Turkiye (Project No. TSA‐2021‐806).
dc.identifier.doi10.1111/jvp.13404
dc.identifier.eissn1365-2885
dc.identifier.endpage331
dc.identifier.issn0140-7783
dc.identifier.issue5
dc.identifier.pmid37488663
dc.identifier.scopus2-s2.0-85165564472
dc.identifier.startpage326
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12172
dc.identifier.volume46
dc.identifier.wosWOS:001035604200001
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofJournal of Veterinary Pharmacology and Therapeutics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectage-related pharmacokinetics
dc.subjectHPLC
dc.subjectintravenous
dc.subjectmeloxicam
dc.subjectsheep
dc.subjectAdministration, Intravenous
dc.subjectAnimals
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectArea Under Curve
dc.subjectHalf-Life
dc.subjectInjections, Intravenous
dc.subjectKinetics
dc.subjectThiazines
dc.subjectThiazoles
dc.subjectnonsteroid antiinflammatory agent
dc.subjectthiazine derivative
dc.subjectthiazole derivative
dc.subjectage
dc.subjectanimal experiment
dc.subjectarea under the curve
dc.subjectArticle
dc.subjectclinical effectiveness
dc.subjectcontrolled study
dc.subjectdose response
dc.subjectdrug clearance
dc.subjectdrug effect
dc.subjectdrug efficacy
dc.subjectdrug half life
dc.subjecthigh performance liquid chromatography
dc.subjectnonhuman
dc.titleAge-related changes in the pharmacokinetics of meloxicam after intravenous administration in sheep
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus13
rdl.citation.wos13
rdl.departmentDepartment of Pharmacology, Faculty of Pharmacy, University of Erzincan Binali Yıldırım, Erzincan, Turkiye.
rdl.oa.statusopen
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)